ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
49 announcements with these filters
CARE Ratings delivered strong FY26 performance with consolidated revenue growth of 18% and PAT growth of 24%. Strategy focuses on scaling global ratings and AI-embedded analytics.
CARE Ratings reported record financial performance in FY26, driven by a 16.1% surge in bank credit offtake and the successful turnaround of its non-ratings subsidiaries to profitability.
CARE Ratings delivered strong FY26 performance with consolidated revenue growing 18% to ₹473cr and PAT up 24% to ₹174cr. The company is pivoting towards AI-driven analytics and expanding its global rating footprint.
CARE Ratings recommended a final dividend of ₹14 per equity share. The record date is June 26, 2026, with payment scheduled by August 1, 2026.
CARE Ratings re-appointed B S R & Co. LLP as Statutory Auditors for five years. The decision ensures audit continuity following board approval.
CARE Ratings reported FY26 consolidated revenue of ₹473.07 Crore, up 18% year-on-year. The Board also recommended a final dividend of ₹14 per share.
CARE Ratings Ltd reported revenue from operations of ₹130.7 Cr (+19.1% YoY) and net profit of ₹53.4 Cr (+23.0% YoY) for Q4 FY26.
CARE Ratings approved FY26 audited financial results and recommended a ₹14 per share final dividend. It also approved a five-year statutory auditor re-appointment.
CARE Ratings Limited allotted 300 equity shares under its ESOP/ESPS scheme on May 4, 2026. This increased the company's paid-up share capital from ₹30,04,88,630 to ₹30,04,91,630.
CARE Ratings Limited allotted 300 equity shares pursuant to ESOP exercises and granted 18,000 new stock options at an exercise price of Rs. 1,590 per share (total value ₹2.86 Crore). The paid-up capital increased to ₹30.05 Crore. Options vest over three years and have a two-year exercise period thereafter.
CARE Ratings Limited, in collaboration with NSE, has commercially launched PaRRVA, a global-first framework for verifying investment performance. The platform independently validates risk-return metrics for financial intermediaries, enhancing market transparency and investor trust.
CARE Ratings Limited received SEBI authorization to commence services as a Past Risk and Return Verification Agency (PaRRVA) from May 4, 2026. This follows the successful completion of a pilot phase initiated under SEBI's April 2025 circular.
CARE Ratings Limited has scheduled a board meeting for May 13, 2026, to consider audited standalone and consolidated financial results for the year ended March 2026. The board will also consider recommending a final dividend for FY 2025-26. Trading window for company shares remains closed until May 15, 2026.
CARE Ratings Ltd has scheduled a Board Meeting on May 13, 2026. The board will consider audited financial results for the quarter and year ended March 31, 2026, and recommend a final dividend for FY2025-26. The trading window remains closed until 48 hours after the results declaration.
Pari Washington India Master Fund, Ltd. sold 76,817 shares of CARE Ratings Limited through the open market on April 21, 2026. This disposal reduced the combined holding of the fund and its PAC from 7.72% to 7.46% of the company's equity share capital.
CARE Ratings Ltd confirmed it does not fall under the Large Corporate category for the financial year 2026-2027. The company reported zero outstanding borrowings as of March 31, 2026, exempting it from mandatory incremental borrowing requirements through debt securities under SEBI framework.
CARE Ratings Limited allotted 1,850 equity shares on April 6, 2026, following the exercise of Employee Stock Options (ESOP). This marginally increased the company's paid-up share capital from ₹30.047 Crore to ₹30.048 Crore. Such allotments are routine rewards to align employee interests with long-term company performance.
CARE Ratings Limited has allotted 1,850 equity shares to employees following the exercise of options under its 2020 ESOP scheme. Consequently, the company's paid-up share capital has increased to Rs. 30,04,88,630.
CARE Ratings Limited submitted its quarterly compliance certificate under Regulation 74(5) of SEBI Regulations for the period ended March 31, 2026. The certificate, issued by KFin Technologies Limited, confirms the processing of security dematerialisation and rematerialisation requests during the quarter.